Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile
Titel:
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile
Auteur:
Mauro, Francesca R. Molica, Stefano Laurenti, Luca Cortelezzi, Agostino Carella, Angelo M. Zaja, Francesco Chiarenza, Annalisa Angrilli, Francesco Nobile, Francesco Marasca, Roberto Musolino, Caterina Brugiatelli, Maura Piciocchi, Alfonso Vignetti, Marco Fazi, Paola Gentile, Giuseppe De Propris, Maria S. Starza, Irene Della Marinelli, Marilisa Chiaretti, Sabina Del Giudice, Ilaria Nanni, Mauro Albano, Francesco Cuneo, Antonio Guarini, Anna FoĆ , Robin